Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. Schwitzer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 - excerpt comes from  an article, “Cancer Society Casts Doubt on Value of Prostate  Cancer Test,”1 … His cancer was removed. His impotence is being managed. … o The lung lesions led to major lung surgery, which detected no malignancy: “I awoke in the recovery … Slide 17: Patient Viewpoints  on Cancer Screening  Controversies  (2 of 2) • “Dr. … too many false positives (suspicious spots that turn  out,  upon  biopsy,  to be nothing) and tumors
  2. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2.PDF
    January 01, 2010 - W MCC 18,194 0.13% 181: RESPIRATORY NEOPLASMS W CC 21,604 0.16% 182: RESPIRATORY NEOPLASMS W/O CC/ … & URETER PROCEDURES FOR NON-NEOPLASM W CC 11,021 0.08% 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … ; other and unspecified primary 3,016 0.02% 42: Secondary malignancies 88,786 0.64% 43: Malignant neoplasm … 19,548 0.14% 45: Maintenance chemotherapy; radiotherapy 63,755 0.46% 46: Benign neoplasm of uterus … 76,963 0.55% 47: Other and unspecified benign neoplasm 63,891 0.46% 48: Thyroid disorders 19,799 0.14%
  3. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2010 - W MCC 44,035 0.12% 181: RESPIRATORY NEOPLASMS W CC 51,926 0.14% 182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,842 0.02% 42: Secondary malignancies 214,010 0.57% 43: Malignantneoplasm without specification of site 8,163 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 46,978 0.13% 45: Maintenance chemotherapy; radiotherapy 158,352 0.42% 46: Benign neoplasm … of uterus 171,187 0.46% 47: Other and unspecified benign neoplasm 152,830 0.41% 48: Thyroid disorders
  4. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2.PDF
    January 01, 2011 - W MCC 17,306 0.12% 181: RESPIRATORY NEOPLASMS W CC 20,773 0.15% 182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 9,902 0.07% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … ; other and unspecified primary 3,033 0.02% 42: Secondary malignancies 87,140 0.63% 43: Malignant neoplasm … 19,198 0.14% 45: Maintenance chemotherapy; radiotherapy 63,512 0.46% 46: Benign neoplasm of uterus … 68,796 0.49% 47: Other and unspecified benign neoplasm 60,810 0.44% 48: Thyroid disorders 18,895 0.14%
  5. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2011 - W MCC 41,892 0.11% 181: RESPIRATORY NEOPLASMS W CC 49,904 0.14% 182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 8,065 0.02% 42: Secondary malignancies 210,548 0.57% 43: Malignantneoplasm without specification of site 8,609 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 45,768 0.12% 45: Maintenance chemotherapy; radiotherapy 159,601 0.43% 46: Benign neoplasm … of uterus 149,385 0.40% 47: Other and unspecified benign neoplasm 144,440 0.39% 48: Thyroid disorders
  6. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
    January 01, 2012 - W MCC 17,087 0.13% 181: RESPIRATORY NEOPLASMS W CC 19,272 0.14% 182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 10,069 0.07% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … ; other and unspecified primary 2,917 0.02% 42: Secondary malignancies 83,841 0.62% 43: Malignant neoplasm … 18,475 0.14% 45: Maintenance chemotherapy; radiotherapy 60,731 0.45% 46: Benign neoplasm of uterus … 57,767 0.43% 47: Other and unspecified benign neoplasm 57,065 0.42% 48: Thyroid disorders 16,796 0.12%
  7. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2012 - W MCC 42,405 0.12% 181: RESPIRATORY NEOPLASMS W CC 47,403 0.13% 182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,786 0.02% 42: Secondary malignancies 206,465 0.57% 43: Malignantneoplasm without specification of site 9,218 0.03% 44: Neoplasms of unspecified nature or uncertain … behavior 45,048 0.12% 45: Maintenance chemotherapy; radiotherapy 157,338 0.43% 46: Benign neoplasm … of uterus 127,128 0.35% 47: Other and unspecified benign neoplasm 138,602 0.38% 48: Thyroid disorders
  8. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core_Weighted.PDF
    January 01, 2013 - W MCC 42,076 0.12% 181: RESPIRATORY NEOPLASMS W CC 43,622 0.12% 182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,609 0.02% 42: Secondary malignancies 200,515 0.56% 43: Malignantneoplasm without specification of site 9,147 0.03% 44: Neoplasms of unspecified nature or uncertain … behavior 42,887 0.12% 45: Maintenance chemotherapy; radiotherapy 158,964 0.45% 46: Benign neoplasm … of uterus 113,052 0.32% 47: Other and unspecified benign neoplasm 132,169 0.37% 48: Thyroid disorders
  9. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core.PDF
    January 01, 2012 - of head and neck 186 0.01% 13: Cancer of stomach 14 0.00% 14: Cancer of colon 79 0.00% 15: Cancer … of uterus 14 0.00% 26: Cancer of cervix 15 0.00% 27: Cancer of ovary 213 0.01% 28: Cancer of other … and unspecified primary 1,422 0.04% 42: Secondary malignancies 1,283 0.04% 43: Malignant neoplasm … 0.06% 45: Maintenance chemotherapy; radiotherapy 32,741 1.02% 46: Benign neoplasm of uterus 48 0.00% … 47: Other and unspecified benign neoplasm 5,936 0.19% 48: Thyroid disorders 917 0.03% 49: Diabetes
  10. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core_Weighted.PDF
    January 01, 2012 - of head and neck 264 0.00% 13: Cancer of stomach <= 50 *.**% 14: Cancer of colon 109 0.00% 15: Cancer … of uterus <= 50 *.**% 26: Cancer of cervix <= 50 *.**% 27: Cancer of ovary 300 0.00% 28: Cancer of … ; other and unspecified primary 2,027 0.03% 42: Secondary malignancies 1,825 0.03% 43: Malignant neoplasm … 0.04% 45: Maintenance chemotherapy; radiotherapy 46,804 0.70% 46: Benign neoplasm of uterus 66 0.00% … 47: Other and unspecified benign neoplasm 8,362 0.13% 48: Thyroid disorders 1,288 0.02% 49: Diabetes
  11. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Dx_Pr_Grps.PDF
    November 08, 2017 - W MCC 6,562 0.12% 181: RESPIRATORY NEOPLASMS W CC 5,516 0.10% 182: RESPIRATORY NEOPLASMS W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 3,442 0.06% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … ; other and unspecified primary 1,151 0.02% 42: Secondary malignancies 28,569 0.53% 43: Malignant neoplasm … 6,336 0.12% 45: Maintenance chemotherapy; radiotherapy 22,662 0.42% 46: Benign neoplasm of uterus … 15,522 0.29% 47: Other and unspecified benign neoplasm 18,092 0.34% 48: Thyroid disorders 3,856 0.07%
  12. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
    January 01, 2006 - of skin 5757 0.01 24: Cancer of breast 84518 0.21 25: Cancer of uterus 38527 0.10 26: Cancer of cervix … Cancer of prostate 89010 0.23 30: Cancer of testis 1869 0.00 31: Cancer of other male genital organs … 802 0.00 32: Cancer of bladder 38773 0.10 33: Cancer of kidney and renal pelvis 44586 0.11 34: Cancer … , other Unspecified primary 7607 0.02 42: Secondary malignancies 241780 0.61 43: Malignant neoplasmneoplasm of uterus 205200 0.52 47: Other unspecified benign neoplasm 165184 0.42 48: Thyroid disorders
  13. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core_Weighted.PDF
    January 01, 2013 - W MCC 42,965 0.12% 181: RESPIRATORY NEOPLASMS W CC 43,265 0.12% 182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,230 0.02% 42: Secondary malignancies 195,925 0.55% 43: Malignantneoplasm without specification of site 8,950 0.03% 44: Neoplasms of unspecified nature or uncertain … behavior 42,635 0.12% 45: Maintenance chemotherapy; radiotherapy 157,135 0.44% 46: Benign neoplasm … of uterus 104,565 0.29% 47: Other and unspecified benign neoplasm 126,435 0.36% 48: Thyroid disorders
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
    November 12, 2013 - (breast, colon, lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology for CINAHL, PsycINFO, EMBASE, and any other databases searched: ("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous)) Filters:Publication
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/HZGtYqL_8u57Gkc6YFctmT
    August 21, 2018 - infection, human papillomavirus (HPV) infection (by genotype), precancer (cervical intraepithelial neoplasia … Fourth, issues regarding HPV-negative cancers and the impli- cations for the relative effectiveness of … Human papillomavirus genotype–specific prevalence across the continuum of cervical neoplasia and cancer … Saraiya M, Unger ER, Thompson TD, et al; HPV Typing of Cancers Workgroup. … US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
  16. digital.ahrq.gov/medical-condition/colorectal-cancer
    January 01, 2024 - Colorectal Cancer The relationship between medication beliefs, patient … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Connected Cancer Care: EHR Communication Networks in Virtual Cancer Care Teams - Final Report. … increased cancer knowledge in a randomized controlled trial. … Cancer Control. 2021 Jan-Dec;28:10732748211036783. doi: 10.1177/10732748211036783.
  17. digital.ahrq.gov/medical-condition/lung-cancer
    January 01, 2024 - Lung Cancer The relationship between medication beliefs, patient activation … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Patients' perceptions of using technology for self-reporting cancer medication safety events from home … Patient perspectives on a patient-facing tool for lung cancer screening. … Methods for using race and ethnicity in prediction models for lung cancer screening eligibility.
  18. digital.ahrq.gov/medical-condition/prostate-cancer
    January 01, 2024 - Prostate Cancer The relationship between medication beliefs, patient … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Patients' perceptions of using technology for self-reporting cancer medication safety events from home … Support Care Cancer. 2024 May 15;32(6):352. doi: 10.1007/s00520-024-08565-5. PMID: 38748294. … Using Electronic Data to Improve Care of Patients With Known or Suspected Cancer - Final Report.
  19. effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
  20. digital.ahrq.gov/sites/default/files/docs/citation/r21hs024984-gray-final-report-2019.pdf
    January 01, 2019 - Structured Abstract: Purpose: Many thousands of cancer patients receive tumor genomic testing yearly … Keywords: Cancer genomics, patient education, tool development, eHealth 2. … Cancer is at the leading edge of this revolution and hundreds of thousands of cancer patients receive … tumor genomic testing yearly. … Adult patients with solid tumors at City of Hope (COH) were eligible to participate if they had somatic